ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645017 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645017; 2) Community: the network communities that were significantly associated with the response to NSC 645017; 3) Molecule: the relationships between components within communities and NSC 645017; 4) MDR: the compounds that were significantly associated with the NSC 645017.

NSC Compound Enrichment Correlation
NSC 680417 Null 0.0133986477026051 0.71225092
NSC 680418 Null 0.0133986477026051 0.46402809
NSC 683555 Camptothecin Derivative 0.0133986477026051 0.70864244
NSC 708785 Null 0.0133986477026051 0.31983889
NSC 710099 Null 0.0133986477026051 0.25496386
NSC 714680 Null 0.0133986477026051 0.020742438
NSC 717201 Null 0.0133986477026051 0.27149779
NSC 724779 1-{[(1R,4S,5R,8S,12R,13R)-1,5-dimethyl-10-(trifluoromethyl)- 11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec-9- en-9-yl]methyl}-4-{[1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(tr ifluoromethyl)-1 0.0133986477026051 0.09264961
NSC 726441 4,11-dihydroxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-naphtho [2,3-f]indole-5,10-dione dihydrochloride 0.0133986477026051 0.16041111
NSC 749076 3-(7-methoxy-3-methyl-1,4-dioxy-quinoxalin-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.0133986477026051 0.14656102
Total:106  Current:41    [First] [Prev] [Next] [Last]